El pronóstico de los tumores carcinoides no metastásicos generalmente es bueno pues son de crecimiento lento y pueden controlarse con tratamiento quirúrgico. (10)

FIGURAS

Tabla 1: Marcadores producidos por los tumores carcinoides según su localización.

Bibliografía.

1. Oberdorfer S, Karzinoide Tumoren des Dünndarmes, Frankfurter Zeitschrift für Pathologie, 1907, 1: 426-429.
2. Libby Ellis, Matthew J Shale and Michel P Coleman, Carcinoid Tumors of the Gastrointestinal Tract: Trends in Incidence in England since 1971. The American Journal of Gastroentelogy 2010; 105: 2563-69.
3. Cornelis JM Lips, Eef GWM Lentjes and Jo WM Höppener, The spectrum of carcinoid tumours and carcinoid syndromes. Ann Clin Biochem 2003; 40: 612-27.
4. Hemminki K et Li X, Incidence trend and risk factor of carcinoid tumors: a nationwide epidemiological study from Sweden. Cancer 2001; 92: 2204-10.
5. Vinay Kumar, Ramzi S. Cotran, Stanley L. Robbins, Patología Humana 7ª edición 2004; 15; 586-7.
6. Chen TH, Lin CJ, Wu RC, Ho YP, Hsu CM et al, The application of miniprobe ultrasonography in the diagnosis of colorectal subepithelial lesion, Chang Gung Med J, 2010; 33: 380-8.
7. Samuel Changm, Dongil Choi, Soon Jin Lee, et al. Neuroendocrine Neoplasms of the Gastrointestinal Tract: Classification, Pathologic Basis, and Imaging Features. Radiographics 2007; 27:1667-1670.
8. Kulke MH, Siu LL, Tepper JE, Fisher G, Jaffe D et al. Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting. J Clin Oncol. 2011; 29:934-43.
9. Moertel CG, Treatment of the carcinoid tumor and the malignant carcinoid syndrome, J Clin Oncol 1983; 1: 727-40.
10. Hans Scherübl, Tumor Biology and Prognosis of Gastrointestinal Carcinoids, J Clin Oncol. 2008; 36: 6012-13.